ALG13 and microcephaly: Specifically, the mutation in the gene ALG‐13 affects N‐linked glycosylation which can disrupt various metabolic pathways and often manifests as microcephaly, hepatomegaly, seizures, developmental delay, and generalized hypotonia [1].